To develop and provide life-enhancing products and technologies with a commitment to quality as the goal at every step of the process.
Hancock Jaffe Laboratories develops life-enhancing bioprosthetic devices and technologies intended to achieve unparalleled outcomes for patients with debilitating cardiovascular diseases. Each device is designed to allow vascular and cardiothoracic surgeons to achieve maximum effectiveness while greatly reducing the time and complexity of current procedures in concert with a commitment to efficient health care delivery.
Venous Valve: Remarkably Mimetic of a Native Venous Valve
The VenoValve®, designed to provide surgeons with the first comprehensive surgical option for the treatment of lower limb chronic deep venous insufficiency, recognized as one of the most disabling and debilitating conditions in the United States and Europe.
Follow this link to learn more about the SAVVE Clinical Trial:venovalve.com
CoreoGraft® – Coronary Artery Bypass Graft: Anatomically and Functionally Mimetic of Free Saphenous Vein Grafts
Bioprosthetic coronary artery bypass graft is specifically designed to address the demands of coronary artery blood flow. The “off the shelf” CoreoGraft® bioprosthesis will allow for more complete revascularization of the diseased heart with the goal of eliminating the need for vein and artery harvesting procedures thus reducing the comorbidities and complications attendant to graft harvesting.